 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 6 | 1/1 | 返回列表 |
| 查看: 1583 | 回復(fù): 5 | ||||
[交流]
【求助】AC2993一期、二期臨床研究申報資料
|
| 跪求AC2993一期和二期臨床研究的申報資料，現(xiàn)要翻譯臨床研究有關(guān)增大劑量的副反應(yīng)、耐受性、安全性等的相關(guān)資料，可惜沒有電子版，本人英文能力有限，翻譯起來比較困難，最好有中文版的，不勝感激！ |
回復(fù)此樓» 收錄本帖的淘帖專輯推薦
 work or phd? |
» 猜你喜歡
參比制劑，自己做的PK數(shù)據(jù)與IF資料報道的數(shù)據(jù)相差很大
已經(jīng)有2人回復(fù)
-
祈求中本子
已經(jīng)有0人回復(fù)
-
藥物學(xué)論文潤色/翻譯怎么收費?
已經(jīng)有282人回復(fù)
-
各位大佬，H口面上什么時候會評？？？
已經(jīng)有30人回復(fù)
-
[求助] 流式死活染 & 單細胞門控設(shè)置被質(zhì)疑，如何優(yōu)化并解釋？
已經(jīng)有1人回復(fù)
-
蛋白穩(wěn)定性實驗與功能實驗不一致
已經(jīng)有11人回復(fù)
-
第4年了，馬上40了，可能我與國基確實無緣吧。。。
已經(jīng)有12人回復(fù)
-
2026年申博藥學(xué)專業(yè)
已經(jīng)有1人回復(fù)
-
2026年山東大學(xué)海洋學(xué)院生物與醫(yī)藥博士招生-李霞課題組
已經(jīng)有0人回復(fù)
-
博士研究生招生
已經(jīng)有0人回復(fù)
-
藥理學(xué)、臨床藥學(xué)方向 調(diào)劑
已經(jīng)有1人回復(fù)
» 本主題相關(guān)價值貼推薦，對您同樣有幫助:
- 常見化驗項目正常參考值及臨床意義-狗和貓
已經(jīng)有11人回復(fù)
- CTD申報資料中 已知雜質(zhì)結(jié)構(gòu)確證 部分該怎么寫呢？
已經(jīng)有11人回復(fù)
- 藥理毒理研究資料17-27號資料
已經(jīng)有6人回復(fù)
- 一類新藥臨床前研究是不是一定要把內(nèi)毒素降下來
已經(jīng)有14人回復(fù)
- 隕陽醫(yī)學(xué)院臨床醫(yī)學(xué)專升本資料
已經(jīng)有7人回復(fù)
- 詢問，中藥五類新藥申報材料中的藥學(xué)研究資料綜述都包括哪些內(nèi)容
已經(jīng)有8人回復(fù)
- 3.1類新藥申報臨床8號資料整理，急
已經(jīng)有15人回復(fù)
- 已獲臨床批件的原進口藥品注冊申報資料，部分資料英文未翻譯，怎么也獲批了呢？
已經(jīng)有6人回復(fù)
- 教育部人文社科申報書“前期研究基礎(chǔ)及資料準(zhǔn)備”能寫出自己曾經(jīng)主持的項目名稱不？
已經(jīng)有4人回復(fù)
- 請教教育部人文社科項目的前期研究基礎(chǔ)及資料準(zhǔn)備怎么寫
已經(jīng)有5人回復(fù)
★ ★ ★ ★ ★
kidant(金幣+5):謝謝回帖交流 2010-11-03 09:10:28
嘉笛(金幣+5): 2010-11-24 10:42:17
kidant(金幣+5):謝謝回帖交流 2010-11-03 09:10:28
嘉笛(金幣+5): 2010-11-24 10:42:17
|
Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination This study has been completed. First Received: September 3, 2002 Last Updated: November 5, 2007 History of Changes Sponsor: Amylin Pharmaceuticals, Inc. Collaborator: Eli Lilly and Company Information provided by: Amylin Pharmaceuticals, Inc. ClinicalTrials.gov Identifier: NCT00044668 Purpose This multi-center, open-label study is designed to examine the effects on long-term glucose control and safety of AC2993 in patients with type 2 diabetes treated with metformin, sulfonylurea, or metformin and sulfonylurea combination. Condition Intervention Phase Diabetes Mellitus, Type 2 Drug: AC2993 (synthetic exendin-4) Phase III Study Type: Interventional Study Design: Allocation: Non-Randomized Control: Uncontrolled Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment Official Title: An Open-Label Study to Examine the Long-Term Effect on Glucose Control (HbA1c) and Safety of AC2993 Given Two Times a Day to Subjects With Type 2 Diabetes Treated With Metformin, a Sulfonylurea, or Metformin and Sulfonylurea Combination Resource links provided by NLM: MedlinePlus related topics: Diabetes Drug Information available for: Exenatide Metformin Metformin hydrochloride U.S. FDA Resources Further study details as provided by Amylin Pharmaceuticals, Inc.: Primary Outcome Measures: •*Examine long-term effect on glucose control of subcutaneously (SC) injected AC2993 administered twice a day (BID) in subjects with type 2 diabetes (T2DM);*Assess long-term safety of SC injected AC2993 administered BID in subjects with T2DM Secondary Outcome Measures: •*Examine long-term effect on various pharmacodynamic measurements of SC injected AC2993 administered BID in subjects with T2DM. Estimated Enrollment: 150 Study Start Date: August 2002 Eligibility Ages Eligible for Study: 20 Years to 75 Years Genders Eligible for Study: Both Accepts Healthy Volunteers: No Criteria Inclusion Criteria: •Subjects with type 2 diabetes •Treated for at least 3 months prior to screening either with metformin, sulfonylurea, or metformin and sulfonylurea combination •BMI 25-45 kg/m^2 •HbA1c between 7.5 % and 12.0 %, inclusive Exclusion Criteria: •Treated with other oral anti-diabetic agents other than metformin and sulfonylureas within 3 months of screening •Patients previously treated with AC2993 •Patients presently treated with insulin Contacts and Locations Please refer to this study by its ClinicalTrials.gov identifier: NCT00044668 Locations Hungary Peterfy Teaching Hospital Budapest, Hungary, H 1076 Diagnostic Units Hungary Kft. Budapest, Hungary, H 1036 Uzsoki Street Municipal Hospital Budapest, Hungary, H 1145 Sponsors and Collaborators Amylin Pharmaceuticals, Inc. Eli Lilly and Company Investigators Study Director: Lisa Porter, MD Amylin Pharmaceuticals, Inc. More Information Additional Information: Link to study results on ClinicalStudyResults.org No publications provided ClinicalTrials.gov Identifier: NCT00044668 History of Changes Other Study ID Numbers: 2993-117 Study First Received: September 3, 2002 Last Updated: November 5, 2007 Health Authority: United States: Food and Drug Administration; Hungary: National Institute of Pharmacy Keywords provided by Amylin Pharmaceuticals, Inc.: exenatide exendin-4 diabetes Amylin Lilly Additional relevant MeSH terms: Diabetes Mellitus Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases Exenatide Metformin Hypoglycemic Agents Physiological Effects of Drugs Pharmacologic Actions |
2樓2010-11-01 14:25:42
★ ★ ★ ★ ★
caoyuan521(金幣+2):謝謝授人以漁！ 2010-11-01 21:19:14
kidant(金幣+3):謝謝回帖交流 2010-11-03 09:10:37
caoyuan521(金幣+2):謝謝授人以漁！ 2010-11-01 21:19:14
kidant(金幣+3):謝謝回帖交流 2010-11-03 09:10:37
|
http://clinicaltrials.gov/ct2/results?term=AC2993 樓主看下這個帖子吧，英語還是自己翻譯吧，可以鍛煉一下水平，翻譯兩三次你就都熟悉了！ 希望對你有幫助！ |
3樓2010-11-01 14:27:05
quchun12
銅蟲 (初入文壇)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 261.5
- 帖子: 30
- 在線: 27.9小時
- 蟲號: 1114445
- 注冊: 2010-10-05
- 專業(yè): 免疫相關(guān)疾病其他科學(xué)問題
呢��！ 
4樓2010-11-03 08:44:24
deeplin
鐵蟲 (初入文壇)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 86.8
- 帖子: 32
- 在線: 3.2小時
- 蟲號: 561747
- 注冊: 2008-05-22
- 專業(yè): 中藥藥效物質(zhì)
5樓2010-11-03 09:00:41
xiefl1984 
木蟲 (小有名氣)
- 應(yīng)助: 31 (小學(xué)生)
- 金幣: 2465.1
- 帖子: 129
- 在線: 26.2小時
- 蟲號: 528140
- 注冊: 2008-03-18
- 專業(yè): 生物大分子結(jié)構(gòu)與功能
★ ★ ★
koria0727(金幣+3):多謝提供。 2010-11-24 10:41:02
嘉笛(金幣+45):謝謝 2010-11-28 10:41:30
koria0727(金幣+3):多謝提供。 2010-11-24 10:41:02
嘉笛(金幣+45):謝謝 2010-11-28 10:41:30
6樓2010-11-24 10:39:02
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 嘉笛 的主題更新
| 6 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 302求調(diào)劑 +4 | 小賈同學(xué)123 2026-03-15 | 8/400 |
|
|---|---|---|---|---|
|
|
[考研] 材料與化工304求B區(qū)調(diào)劑 +7 | 邱gl 2026-03-11 | 8/400 |
|
|
|
[考研] 278求調(diào)劑 +3 | Yy7400 2026-03-13 | 3/150 |
|
|
[考研] 一志愿，福州大學(xué)材料專碩339分求調(diào)劑 +3 | 木子momo青爭 2026-03-15 | 3/150 |
|
|
|
[基金申請] 國自科面上基金字體 +6 | iwuli 2026-03-12 | 7/350 |
|
|
|
[考研] 304求調(diào)劑 +4 | ahbd 2026-03-14 | 4/200 |
|
|
|
[考研] 312求調(diào)劑 +3 | 陌宸希 2026-03-16 | 4/200 |
|
|
|
[考研] 070305求調(diào)劑 +3 | mlpqaz03 2026-03-14 | 4/200 |
|
|
|
[考研] 材料工程327求調(diào)劑 +3 | xiaohe12w 2026-03-11 | 3/150 |
|
|
|
[考研] 材料080500調(diào)劑求收留 +3 | 一顆meteor 2026-03-13 | 3/150 |
|
|
|
[考研] 招收0805（材料）調(diào)劑 +3 | 18595523086 2026-03-13 | 3/150 |
|
|
|
[考研] 279求調(diào)劑 +3 | 抓著星星的女孩 2026-03-10 | 3/150 |
|
|
|
[考研] 材料與化工（0856）304求B區(qū)調(diào)劑 +6 | 邱gl 2026-03-12 | 7/350 |
|
|
|
[考研] 材料與化工求調(diào)劑一志愿 985 總分 295 +8 | dream…… 2026-03-12 | 8/400 |
|
|
|
[考研] 四川大學(xué)085601材料工程專碩 初試294求調(diào)劑 +4 | 祝我們好在冬天 2026-03-11 | 4/200 |
|
|
|
[考研] 329求調(diào)劑 +3 | miaodesi 2026-03-12 | 4/200 |
|
|
|
[考研] 274求調(diào)劑 +3 | S.H1 2026-03-12 | 3/150 |
|
|
|
[考研] 296求調(diào)劑 +3 | 大口吃飯 身體健 2026-03-13 | 3/150 |
|
|
|
[考研] 08食品或輕工求調(diào)劑，本科發(fā)表3篇sci一區(qū)top論文，一志愿南師大食品科學(xué)與工程 +3 | 我是一個兵， 2026-03-10 | 3/150 |
|
|
|
[考研] 279求調(diào)劑 +3 | 莫xiao 2026-03-10 | 4/200 |
|